Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Donghua Liu
Institution:
Affiliated Hospital of Qingdao University
Observed institutions:
Affiliated Hospital of Qingdao University,
First Affiliated Hospital of Xi'an Jiaotong University,
Xi'an Jiaotong University
ORCID:
0000-0002-5830-9540
Observed ORCID:
0000-0002-5830-9540
OpenAlex ID:
A5100317008
Discovery of a peptide proteolysis-targeting chimera (PROTAC) drug of p300 for prostate cancer therapy
2024
·
Dize Zhang
, Bohan Ma
, et al.
·
EBioMedicine
·
41
PDF
CDK4/6 inhibitors in breast cancer therapy: mechanisms of drug resistance and strategies for treatment
2025
·
Tong Gao
, Ying Sun
, et al.
·
Frontiers in Pharmacology
·
33
PDF
Structure-based artificial intelligence-aided design of MYC-targeting degradation drugs for cancer therapy
2025
·
Donghua Liu
, Yize Jiang
, et al.
·
Biochemical and Biophysical Research Communications
·
6
Quality of life and associated psychosocial factors in patients with invasive breast cancer receiving long-term anti-HER2 targeted therapy: a cross-sectional study
2026
·
Xianghua Quan
, Haibo Wang
, et al.
·
Frontiers in Pharmacology
PDF
Show more works
View as search
Works count:
4
Citation count:
80
H-index:
3
I10-index:
2
Year
Topic
Type